1. Home
  2. FRSH vs GH Comparison

FRSH vs GH Comparison

Compare FRSH & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Freshworks Inc.

FRSH

Freshworks Inc.

HOLD

Current Price

$12.36

Market Cap

3.7B

Sector

Technology

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$102.76

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRSH
GH
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
14.1B
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
FRSH
GH
Price
$12.36
$102.76
Analyst Decision
Buy
Strong Buy
Analyst Count
16
21
Target Price
$19.53
$96.48
AVG Volume (30 Days)
3.5M
2.0M
Earning Date
02-10-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$810,640,000.00
$902,569,000.00
Revenue This Year
$18.20
$35.00
Revenue Next Year
$13.36
$26.80
P/E Ratio
N/A
N/A
Revenue Growth
18.18
30.38
52 Week Low
$10.51
$29.91
52 Week High
$19.77
$112.43

Technical Indicators

Market Signals
Indicator
FRSH
GH
Relative Strength Index (RSI) 48.51 56.39
Support Level $12.42 $96.28
Resistance Level $12.76 $105.01
Average True Range (ATR) 0.41 4.05
MACD -0.08 -1.12
Stochastic Oscillator 12.67 48.98

Price Performance

Historical Comparison
FRSH
GH

About FRSH Freshworks Inc.

Freshworks Inc provides software as a service platform that enables small and medium-sized businesses to support customers through e-mail, phone, website, and social networks. It offers solutions that serve the needs of users in the CS and ITSM categories and has also expanded its offering with Sales and Marketing automation products. These product offerings enable organizations to acquire, engage, and serve their customers and employees. The group derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and Other regions.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: